FIRST TRUST ADVISORS LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2021$114,000
-57.8%
22,771
+1.5%
0.00%
Q3 2021$270,000
+24.4%
22,425
+119.0%
0.00%
Q2 2021$217,000
-18.1%
10,241
+8.3%
0.00%
Q1 2021$265,000
-71.7%
9,457
-73.8%
0.00%
-100.0%
Q4 2020$938,000
+68.1%
36,091
+140.2%
0.00%0.0%
Q3 2020$558,000
+151.4%
15,024
+247.4%
0.00%
Q2 2020$222,000
-51.8%
4,325
-53.0%
0.00%
-100.0%
Q3 2017$461,000
+2.9%
9,205
-4.8%
0.00%0.0%
Q2 2017$448,000
-37.2%
9,673
-52.1%
0.00%
-50.0%
Q1 2017$713,00020,2020.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders